Jacob Gary S Insider Trades

Insider Trading History

Track insider trading activity for Jacob Gary S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
OKYO Pharma Limited
OKYO Pharma Limited OKYO
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Mar 13, 2025 Sale
$24.3k 16,667 shares
$1.46
$1.66
Hepion Pharmaceuticals
Hepion Pharmaceuticals HEPA
Director
Holding Value $6.13k 102,120 shares
Last Trade
Feb 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9M 85,000 shares
$128.00
$0.06
OKYO Pharma Limited
OKYO Pharma Limited OKYO
Chief Executive Officer
Holding Value $20.8k 12,500 shares
Last Trade
May 19, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$41.6k 12,500 shares
$3.33
$1.66
OKYO Pharma Limited
OKYO Pharma Limited OKYO
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 16, 2022 Sale
No data
No data
$1.66
Virpax Pharmaceuticals
Virpax Pharmaceuticals VRPX
Director
Holding Value $1.21 12,091 shares
Last Trade
Jan 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4M 12,091 shares
$857.50
$0.00
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.78k 223 shares
$7.98
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$357k 44,734 shares
$7.98
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$6.02k 755 shares
$7.98
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.74k 218 shares
$7.98
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$230k 28,858 shares
$7.98
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.34k 293 shares
$7.98
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$4.23k 530 shares
$7.98
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $107k 76,106 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.78k 223 shares
$7.98
$1.40
Hepion Pharmaceuticals
Hepion Pharmaceuticals HEPA
Director
Holding Value $20.6k 342,785 shares
Last Trade
May 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$413M 250,000 shares
$1,650.00
$0.06
Virpax Pharmaceuticals
Virpax Pharmaceuticals VRPX
Director
Holding Value $0 0 shares
Last Trade
Apr 26, 2021 Sale
$21.6M 20,225 shares
$1,067.50
$0.00
Virpax Pharmaceuticals
Virpax Pharmaceuticals VRPX
Director
Holding Value $1.32 13,183 shares
Last Trade
Apr 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.2M 13,183 shares
$1,155.25
$0.00
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $30k 21,452 shares
Last Trade
Mar 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.8k 1,900 shares
$10.42
$1.40
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $30.7k 21,922 shares
Last Trade
Mar 23, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.89k 470 shares
$10.40
$1.40
Virpax Pharmaceuticals
Virpax Pharmaceuticals VRPX
Director
Holding Value $0.35 3,500 shares
Last Trade
Feb 17, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.71M 3,500 shares
$1,632.50
$0.00
Hepion Pharmaceuticals
Hepion Pharmaceuticals HEPA
Director
Holding Value $724 12,059 shares
Last Trade
Dec 01, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.8M 12,000 shares
$1,650.00
$0.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up